J0578Drugs Administered Other than Oral Method

Injection, buprenorphine extended release (brixadi), greater than 7 days and up

Short description: Inj brixadi, more than 7 day

Effective date: April 1, 2024
Termination date: —

Related codes (J-series)

J0013Esketamine, nasal spray J0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injection J0121Inj., omadacycline, 1 mg J0122Inj., eravacycline, 1 mg J0129Abatacept injection J0130Abciximab injection J0131Inj, acetaminophen (nos)J0132Acetylcysteine injection J0133Acyclovir injection J0134Inj acetaminophen -fresenius J0135Adalimumab injection

Frequently asked questions

What is HCPCS code J0578?

J0578 is a HCPCS Level II code for Injection, buprenorphine extended release (brixadi), greater than 7 days and up.

What category is HCPCS code J0578 in?

J0578 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.

When did HCPCS code J0578 become effective?

J0578 has been effective since April 1, 2024, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.